CVS Health Corporation (NYSE:CVS) Underpriced by 16.2%


The Comerica Securities Inc holds 61,131 shares with $4.92M value, up from 23,662 last quarter.

The company now has an insider ownership of 0.1 Percent and Institutional ownership of 85 Percent. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. It has outperformed by 13.30% the S&P500.

Janney Montgomery Scott Llc decreased Cvs Health Corp (CVS) stake by 8% reported in 2017Q2 SEC filing. According to today's trading volume CVS Health Corporation is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days. Pzena Inv Management Limited Liability Company has 0.31% invested in CVS Health Corp (NYSE:CVS).

21 analysts on average are expecting CVS Health Corporation to report earnings of $1.9 per share for the current quarter.

When considering a new stock purchase, a lot of investors find out how Wall Street analysts feel about the company before they buy in. About 54,262 shares traded. In the most recent financial results released by CVS Health Corporation, for the quarter ending on 2017-09-30, the company posted EPS of 1.5. It has underperformed by 41.10% the S&P500.

Investors sentiment increased to 2.26 in Q2 2017. Quick and current ratio is valued at 0.6 and 1 respectively. 181.67 million shares or 1.84% more from 178.39 million shares in 2017Q1 were reported. Nuveen Asset Ltd, Illinois-based fund reported 107,622 shares. The shares went down by -1.54% in value last month. Salem Capital Mngmt has 73,410 shares for 3.3% of their portfolio. Clark Estates Ny, a New York-based fund reported 530,702 shares. Eagle Ridge holds 2.7% or 179,847 shares in its portfolio. Group Inc One Trading Limited Partnership invested in 460,284 shares. Massachusetts Financial Svcs Com Ma has 0% invested in YPF SA (ADR) (NYSE:YPF). Raymond James Tru Na holds 26,098 shares or 0.04% of its portfolio. Northern reported 15.62M shares or 0.35% of all its holdings. Anthem Inc Com Stk now has $55.99B valuation. The ex-dividend date of this dividend was Monday, October 23rd. The stock has "Strong Buy" rating by S&P Research on Monday, November 2. Therefore 88% are positive. Chevron Corporation had 92 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Thursday, October 6 by UBS. Jefferies maintained CVS Health Corp (NYSE:CVS) rating on Friday, September 15. The rating was upgraded by Robert W. Baird on Monday, August 3 to "Outperform". 44,270 were reported by Fincl Bank Pictet And Cie (Asia). Robert W. Baird initiated the stock with "Outperform" rating in Friday, January 22 report. As per Tuesday, November 15, the company rating was upgraded by Wells Fargo. Stifel Nicolaus maintained the stock with "Buy" rating in Wednesday, April 12 report. Ftb Advisors Incorporated holds 480 shares or 0% of its portfolio. CVS's profit will be $1.92 billion for 9.27 P/E if the $1.90 EPS becomes a reality.

CVS Health Corporation's sales for the past 5 years rolls at 10.60%, exhibiting an EPS growth from quarter-to-quarter at -12.10%. Lombard Odier Asset Mngmt (Switzerland) stated it has 0.04% in CVS Health Corp (NYSE:CVS). Bridgeway Inc stated it has 0.6% in CVS Health Corp (NYSE:CVS). When we look at the Volatility of the company, Week Volatility is at 3.03% whereas Month Volatility is at 2.99%. It also upped Schlumberger Ltd (NYSE:SLB) stake by 19,084 shares and now owns 206,619 shares. Therefore 63% are positive. CVS Health had 52 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Tuesday, August 8 by Oppenheimer. The rating was maintained by Oppenheimer with "Outperform" on Friday, August 28. The rating was downgraded by Atlantic Securities to "Neutral" on Monday, February 6. They issued a "hold" rating and a $83.00 price objective for the company. The firm has "Overweight" rating given on Wednesday, September 16 by JP Morgan. Jefferies has "Hold" rating and $76 target. Another trade for 230,510 shares valued at $18.44 million was sold by Denton David M. The stock of CVS Health Corp (NYSE:CVS) has "Overweight" rating given on Thursday, March 10 by Barclays Capital. Colgate-Palmolive Company is given 1 buy-equivalent recommendations, 0 sells and 17 holds.

Investors of record on Tuesday, October 24th were issued a $0.50 dividend. It dropped, as 84 investors sold CVS shares while 559 reduced holdings.

A number of other hedge funds have also recently made changes to their positions in the stock. Fjarde Ap holds 0.38% of its portfolio in CVS Health Corp (NYSE:CVS) for 235,241 shares. Acrospire Investment Management LLC boosted its stake in CVS Health Corporation by 542.2% in the second quarter.

CVS Health Corporation (NYSE:CVS) gross margin percentage stands at 15.5% while its operating margin for the past trailing twelve month is 5.2 percent and its overall profit margin (ttm) is 2.8 Percent. Pointstate Capital Ltd Partnership reported 757,013 shares. Arizona State Retirement System invested 0.38% in CVS Health Corp (NYSE:CVS). 25,487 are owned by Northstar Gp. First City Capital Management Inc. boosted its stake in CVS Health Corporation by 0.3% in the 1st quarter. Stanley invested in 43,289 shares. Tarbox Family Office holds 0.02% or 407 shares in its portfolio. Silvercrest Asset Grp Limited Co invested 0.49% of its portfolio in CVS Health Corp (NYSE:CVS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.